Tzianabos Arthur is a director of Stoke Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Q32 Bio Inc.
27 Mar 24
4
Homology Medicines, Inc.
15 Feb 24
4
Stoke Therapeutics, Inc.
15 Feb 24
4
Stoke Therapeutics, Inc.
15 Jun 23
4
Homology Medicines, Inc.
15 Jun 23
4
Homology Medicines, Inc.
11 Jan 23
4
Homology Medicines, Inc.
4 Jan 23
4
Akouos, Inc.
2 Dec 22
4
Akouos, Inc.
27 Jun 22
4
Stoke Therapeutics, Inc.
8 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | QTTB Q32 Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 16.82 | 12,767 | 214.74 k | 12,767 |
9 Jan 24 | QTTB Q32 Bio | Common Stock | Sell | Dispose S | No | Yes | 0.5711 | 13,037 | 7.45 k | 128,778 |
1 Jan 24 | QTTB Q32 Bio | Common Stock | Option exercise | Acquire M | No | No | 0 | 19,140 | 0.00 | 141,815 |
1 Jan 24 | QTTB Q32 Bio | Common Stock | Option exercise | Acquire M | No | No | 0 | 14,280 | 0.00 | 122,675 |
1 Jan 24 | QTTB Q32 Bio | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 19,140 | 0.00 | 19,720 |
1 Jan 24 | QTTB Q32 Bio | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 14,280 | 0.00 | 0 |
14 Jun 23 | QTTB Q32 Bio | Option Common Stock | Grant | Acquire A | No | No | 1.03 | 23,000 | 23.69 k | 23,000 |
13 Jun 23 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 12.46 | 19,441 | 242.23 k | 19,441 |
9 Jan 23 | QTTB Q32 Bio | Common Stock | Sell | Dispose S | No | Yes | 1.3905 | 10,616 | 14.76 k | 108,395 |